Author

Ingrid Tomljanović

Erasmus MCORCID 0000-0002-3296-1856Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Alastair D.G. LambiD· 1 shared Aristotelis A. ChatziioannouiD· 1 shared Charlotte Lynne BevaniD· 1 shared Clémentine Le MagneniD· 1 shared Damien A. LeachiD· 1 shared Dimitrios DoultsinosiD· 1 shared Eleftherios D. PilalisiD· 1 shared I.E. Bridges· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alastair D.G. LambORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer.

Dimitrios Doultsinos, Ingrid Tomljanović, Eleftherios D. Pilalis, Sophia M. Abusamra, Romuald Parmentier, I.E. Bridges, Sandy Figiel, Yanis Zekri, Joanna Hester, Damien A. Leach, Charlotte Lynne Bevan, Alastair D.G. Lamb, Wilbert T. Zwart, Aristotelis A. Chatziioannou, Clémentine Le Magnen, Ian Geoffrey Mills

This paper identifies IRE1 activity as a regulator of prostate cancer cell lineage states and shows its role in predicting prognosis and treatment response across localized and metastatic disease.

bioRxiv · Mar 13, 2025 · PreprintCancer Biology